U.S. Home Infusion Therapy Market Size & Outlook
U.S. home infusion therapy market, 2018-2030 (US$M)
Related Markets
U.S. home infusion therapy market highlights
- The U.S. home infusion therapy market generated a revenue of USD 19,078.9 million in 2023 and is expected to reach USD 31,787.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, anti-infective was the largest revenue generating application in 2023.
- Chemotherapy is the most lucrative application segment registering the fastest growth during the forecast period.
Home infusion therapy market data book summary
| Market revenue in 2023 | USD 19,078.9 million |
| Market revenue in 2030 | USD 31,787.2 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Anti-infective |
| Fastest growing segment | Chemotherapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
| Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
Other key industry trends
- In terms of revenue, U.S. accounted for 53.1% of the global home infusion therapy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 31,787.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Home Infusion Therapy Market Scope
Home Infusion Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. home infusion therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 27.03% in 2023. Horizon Databook has segmented the U.S. home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. holds a major share of the North American home infusion therapy market owing to factors such as rising number of government programs & initiatives to promote awareness about the benefits of home infusion therapy. The benefits include cost efficiency, safety, and improved mobility. The larger market share of the country can be attributed to the presence of traditional short-term infusion therapies.
In addition, increasing need for long-term therapies by patients is driving market growth in the U.S. The expanding patient pool in the U.S. can be attributed to the rising geriatric population requiring sustained therapy and improved access to healthcare needs. Home healthcare offers benefits such as reduced healthcare cost and enhanced patient mobility, among others. Due to this, patients, nowadays, prefer home healthcare over acute care settings, resulting in high penetration of alternate site and home infusion services. Moreover, availability of high-quality home infusion products and presence of an extensive pipeline of infusible drugs are contributing to market growth.
Moreover, according to Biologics Price Competition and Innovation Act (BPCI Act), March 2020 onwards, all biologics will be required to be submitted and approved via BLA and even pending, tentatively approved 505(b) 2 applications will not be accepted by the FDA post March 23rd, 2020. Moreover, all the biologics previously approved via NDA and approved marketing applications will be “deemed to be a license” as per Section 351 of the PHS Act. Such complex and rigorous regulations are anticipated to increase the regulatory process for infusion systems.
Reasons to subscribe to U.S. home infusion therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. home infusion therapy market databook
-
Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. home infusion therapy market size, by application, 2018-2030 (US$M)
U.S. Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
